Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients

This is a feasibility study to determine if anti-inflammatory cytokines can be concentrated from patients with osteoarthritis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

OrthoIndy, Indianapolis, Indiana, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

radiographic evidence of osteoarthritis
signed informed consent

Exclusion criteria

Pregnancy
< 18 years of age
blood clotting disorder or active hematologic cancer
undergoing chemotherapy
history of rheumatoid arthritis
septic joint or fracture
active infection or history of chronic infection
use of cytokine blocking drugs with the last 6 months
intra-articular steroid or hyaluronic acid (HA) injection within last 6 months

Treatment and study plan

Primary outcomes

Measure anti-inflammatory cytokines

Time frame: immediately after processing

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Registry information

Official study title

A Feasibility Study to Determine the Up-regulation of Anti-inflammatory Cytokines in Whole Blood From Patients With Osteoarthritis

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Jan 18, 2010
Registry last updated: Mar 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed